A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.

W. Jäger, Willi Sauerbrei, Erin Beck, Maximilian C. Stumpfe, Werner Meier, W Kühn, F. Jänicke

PubMed · 1996 · 33 citations · 0 references

Concepts

Abstract

This randomized study gives evidence that a reduction of gonadotrophins by GnRH-analogues do not substantially improve the outcome of progressive ovarian cancer.